COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
EPA:CRI - Euronext Paris - Matif - FR0000130692 - Common Stock - Currency: EUR
Taking everything into account, CRI scores 3 out of 10 in our fundamental rating. CRI was compared to 16 industry peers in the Industrial Conglomerates industry. CRI may be in some trouble as it scores bad on both profitability and health. CRI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year CRI was profitable.
In the past year CRI had a positive cash flow from operations.
CRI had positive earnings in 4 of the past 5 years.
In multiple years CRI reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.72%, CRI is doing worse than 81.25% of the companies in the same industry.
CRI's Return On Equity of 2.33% is on the low side compared to the rest of the industry. CRI is outperformed by 81.25% of its industry peers.
CRI has a Return On Invested Capital of 5.11%. This is in the lower half of the industry: CRI underperforms 68.75% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRI is below the industry average of 6.82%.
The last Return On Invested Capital (5.11%) for CRI is above the 3 year average (4.65%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.72% | ||
| ROE | 2.33% | ||
| ROIC | 5.11% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
CRI has a worse Profit Margin (1.00%) than 87.50% of its industry peers.
In the last couple of years the Profit Margin of CRI has declined.
Looking at the Operating Margin, with a value of 6.54%, CRI is doing worse than 75.00% of the companies in the same industry.
CRI's Operating Margin has been stable in the last couple of years.
CRI's Gross Margin of 28.34% is on the low side compared to the rest of the industry. CRI is outperformed by 93.75% of its industry peers.
CRI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.54% | ||
| PM (TTM) | 1% | ||
| GM | 28.34% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRI is destroying value.
The number of shares outstanding for CRI has been increased compared to 1 year ago.
Compared to 5 years ago, CRI has more shares outstanding
The debt/assets ratio for CRI has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.50, we must say that CRI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CRI (1.50) is worse than 75.00% of its industry peers.
The Debt to FCF ratio of CRI is 14.78, which is on the high side as it means it would take CRI, 14.78 years of fcf income to pay off all of its debts.
CRI has a Debt to FCF ratio (14.78) which is in line with its industry peers.
CRI has a Debt/Equity ratio of 1.05. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.05, CRI is doing worse than 62.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 14.78 | ||
| Altman-Z | 1.5 |
ROIC/WACC0.74
WACC6.86%
2.3 Liquidity
CRI has a Current Ratio of 1.25. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
CRI has a worse Current ratio (1.25) than 68.75% of its industry peers.
A Quick Ratio of 0.82 indicates that CRI may have some problems paying its short term obligations.
CRI has a Quick ratio of 0.82. This is in the lower half of the industry: CRI underperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1749.48%, which is quite impressive.
Measured over the past years, CRI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -14.59% on average per year.
Looking at the last year, CRI shows a quite strong growth in Revenue. The Revenue has grown by 11.85% in the last year.
Measured over the past years, CRI shows a small growth in Revenue. The Revenue has been growing by 3.10% on average per year.
EPS 1Y (TTM)1749.48%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%518.18%
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%15.47%
3.2 Future
The Earnings Per Share is expected to grow by 29.06% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.76% on average over the next years.
EPS Next Y146.66%
EPS Next 2Y74.67%
EPS Next 3Y29.06%
EPS Next 5YN/A
Revenue Next Year9.12%
Revenue Next 2Y8.09%
Revenue Next 3Y6.76%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 34.63, which means the current valuation is very expensive for CRI.
CRI's Price/Earnings ratio is rather expensive when compared to the industry. CRI is more expensive than 81.25% of the companies in the same industry.
When comparing the Price/Earnings ratio of CRI to the average of the S&P500 Index (26.82), we can say CRI is valued slightly more expensively.
CRI is valuated reasonably with a Price/Forward Earnings ratio of 10.17.
CRI's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRI is cheaper than 81.25% of the companies in the same industry.
CRI is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.63 | ||
| Fwd PE | 10.17 |
4.2 Price Multiples
CRI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRI is cheaper than 62.50% of the companies in the same industry.
CRI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRI is cheaper than 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.61 | ||
| EV/EBITDA | 7.41 |
4.3 Compensation for Growth
CRI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRI's earnings are expected to grow with 29.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y74.67%
EPS Next 3Y29.06%
5. Dividend
5.1 Amount
CRI has a Yearly Dividend Yield of 1.12%.
With a Dividend Yield of 1.12, CRI pays less dividend than the industry average, which is at 12.95. 81.25% of the companies listed in the same industry pay a better dividend than CRI!
With a Dividend Yield of 1.12, CRI pays less dividend than the S&P500 average, which is at 2.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.12% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y74.67%
EPS Next 3Y29.06%
EPA:CRI (8/1/2025, 7:00:00 PM)
11.08
-0.06 (-0.54%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners9.98%
Inst Owner ChangeN/A
Ins Owners64.27%
Ins Owner ChangeN/A
Market Cap275.78M
Analysts75.56
Price Target13.73 (23.92%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.12% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.63 | ||
| Fwd PE | 10.17 | ||
| P/S | 0.38 | ||
| P/FCF | 9.61 | ||
| P/OCF | 6.2 | ||
| P/B | 0.88 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.41 |
EPS(TTM)0.32
EY2.89%
EPS(NY)1.09
Fwd EY9.83%
FCF(TTM)1.15
FCFY10.41%
OCF(TTM)1.79
OCFY16.14%
SpS29.31
BVpS12.59
TBVpS-0.27
PEG (NY)0.24
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.72% | ||
| ROE | 2.33% | ||
| ROCE | 6.99% | ||
| ROIC | 5.11% | ||
| ROICexc | 6.21% | ||
| ROICexgc | 14.36% | ||
| OM | 6.54% | ||
| PM (TTM) | 1% | ||
| GM | 28.34% | ||
| FCFM | 3.93% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexcg growth 3Y-6.3%
ROICexcg growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 14.78 | ||
| Debt/EBITDA | 4.24 | ||
| Cap/Depr | 52.67% | ||
| Cap/Sales | 2.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.27% | ||
| Profit Quality | 393.15% | ||
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 1.5 |
F-Score7
WACC6.86%
ROIC/WACC0.74
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1749.48%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%518.18%
EPS Next Y146.66%
EPS Next 2Y74.67%
EPS Next 3Y29.06%
EPS Next 5YN/A
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%15.47%
Revenue Next Year9.12%
Revenue Next 2Y8.09%
Revenue Next 3Y6.76%
Revenue Next 5YN/A
EBIT growth 1Y84.88%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year145.94%
EBIT Next 3Y48.76%
EBIT Next 5YN/A
FCF growth 1Y152.76%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y253.45%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%